Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20100829004655N9Phase 2Completed
Phase 2, randomised trial of prilocaine, lavender oil and enoxaparin (3 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Injection site pain intensity and Patient comfort. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20100829004655N9.